In accordance with our results, low HLA-DQA1 expression was associated with poor prognosis in hepatocellular carcinoma, lung cancer, breast cancer, and soft tissue sarcoma; its reduction indicated the presence of an immunosuppressive microenvironment and invasive disease [29,30,31,32]. This evidence concerns the gene HLA-DQA1 and breast carcinoma.